Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial.

Cooper SA, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N, Haig C, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sirisena C, Sullivan F.

Trials. 2016 Jul 29;17:370. doi: 10.1186/s13063-016-1370-9.

2.

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.

Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL.

Alzheimers Res Ther. 2015 Jun 25;7(1):39. doi: 10.1186/s13195-015-0122-5. eCollection 2015.

3.

Global epidemiology of dementia: Alzheimer's and vascular types.

Rizzi L, Rosset I, Roriz-Cruz M.

Biomed Res Int. 2014;2014:908915. doi: 10.1155/2014/908915. Epub 2014 Jun 25. Review.

4.

Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Lekoubou A, Echouffo-Tcheugui JB, Kengne AP.

BMC Public Health. 2014 Jun 26;14:653. doi: 10.1186/1471-2458-14-653. Review.

5.

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.

Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sullivan F.

Trials. 2014 Jun 3;15:202. doi: 10.1186/1745-6215-15-202.

6.

Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease.

Ji Y, Liu M, Huo YR, Liu S, Shi Z, Liu S, Wisniewski T, Wang J.

Dement Geriatr Cogn Disord. 2013;36(3-4):163-70. doi: 10.1159/000350872. Epub 2013 Jul 23.

7.

Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.

Obisesan TO, Gillum RF, Johnson S, Umar N, Williams D, Bond V, Kwagyan J.

Int J Alzheimers Dis. 2012;2012:568382. doi: 10.1155/2012/568382. Epub 2012 Apr 17.

8.

Interactions between genetic admixture, ethnic identity, APOE genotype and dementia prevalence in an admixed Cuban sample; a cross-sectional population survey and nested case-control study.

Teruel BM, Rodríguez JJ, McKeigue P, Mesa T TC, Fuentes E, Cepero A AV, Hernandez MA, Copeland J R M JR, Ferri CP, Prince MJ.

BMC Med Genet. 2011 Mar 24;12:43. doi: 10.1186/1471-2350-12-43.

9.
10.

Financial capacity of older African Americans with amnestic mild cognitive impairment.

Triebel KL, Okonkwo OC, Martin R, Griffith HR, Crowther M, Marson DC.

Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):365-71. doi: 10.1097/WAD.0b013e3181e7cb05.

11.

Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

He J, Farias S, Martinez O, Reed B, Mungas D, Decarli C.

Arch Neurol. 2009 Nov;66(11):1393-9. doi: 10.1001/archneurol.2009.252.

12.

Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001.

Hall KS, Gao S, Baiyewu O, Lane KA, Gureje O, Shen J, Ogunniyi A, Murrell JR, Unverzagt FW, Dickens J, Smith-Gamble V, Hendrie HC.

Alzheimers Dement. 2009 May;5(3):227-33. doi: 10.1016/j.jalz.2009.01.026.

13.

A comparison of cardiovascular disease risk factor biomarkers in African Americans and Yoruba Nigerians.

Deeg M, Baiyewu O, Gao S, Ogunniyi A, Shen J, Gureje O, Taylor S, Murrell J, Unverzagt F, Smith-Gamble V, Evans R, Dickens J, Hendrie H, Hall K.

Ethn Dis. 2008 Autumn;18(4):427-33.

14.

A comparative study to screen dementia and APOE genotypes in an ageing East African population.

Chen CH, Mizuno T, Elston R, Kariuki MM, Hall K, Unverzagt F, Hendrie H, Gatere S, Kioy P, Patel NB, Friedland RP, Kalaria RN.

Neurobiol Aging. 2010 May;31(5):732-40. doi: 10.1016/j.neurobiolaging.2008.06.014. Epub 2008 Aug 13.

15.

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P; World Federation of Neurology Dementia Research Group.

Lancet Neurol. 2008 Sep;7(9):812-26. doi: 10.1016/S1474-4422(08)70169-8. Epub 2008 Jul 28. Review. Erratum in: Lancet Neurol. 2008 Oct;7(10):867.

16.

Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden.

Murray AM.

Adv Chronic Kidney Dis. 2008 Apr;15(2):123-32. doi: 10.1053/j.ackd.2008.01.010. Review.

17.

Genetics of Alzheimer's disease: a centennial review.

Ertekin-Taner N.

Neurol Clin. 2007 Aug;25(3):611-67, v. Review.

Items per page

Supplemental Content

Write to the Help Desk